Buzzard Pharmaceuticals

buzzard pharmaceuticals is a biopharmaceutical development company. we are developing isunakinra, an il-1 inhibitor for the treatment of cancer. isunakinra (ebi-005) is a recombinant protein binding to the il1r1 with high potency. il-1 mediates the recruitment of immunesuppressive myeloid cells (pmn-mdscs, neutrophils and t2 macrophages) to the tumor - that inhibit cd8 t cells from entering the tumor and killing tumor cells. moreover, il-1 stimulates angiogensis and tumor spread.